AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Tofastar OD Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Tofacitinib (11mg)

Overview Tofastar OD Tablet

Arthritis and inflammatory bowel disease may be managed with RheumaStar OD tablets, effective against moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication reduces joint pain, inflammation, and swelling, thereby slowing joint deterioration. RheumaStar OD may be prescribed alone or in conjunction with other treatments. These tablets can be ingested with or without food, ideally at the same time daily. Dosage is individualized based on your health status and other medications. Always adhere to your physician's prescribed regimen; discontinuation should only occur under their guidance to prevent condition exacerbation. Common side effects include upper respiratory infections, headaches, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, side effects, such as blood clots and gastrointestinal perforations, require immediate medical attention. Discuss any concerns regarding side effects with your doctor. Pre-treatment blood work may be necessary, and initiation is contraindicated during infection. Prior to commencing treatment, inform your physician of any history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or thromboembolic events. RheumaStar OD increases infection susceptibility; avoid contact with contagious individuals (e.g., those with chickenpox, measles, or influenza). This medication is not approved for use in individuals under 18 years of age, and its use during pregnancy or lactation should only be considered if the benefits outweigh potential risks. Regular medical monitoring may be required.

Uses of Tofastar OD Tablet

Managing rheumatoid, psoriatic, and ankylosing spondylitis, plus ulcerative colitis.

Major Benefits of Tofastar OD Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tofastar OD Tablet can be administered with or without food, though consistent timing is recommended.

Common Side effects of Tofastar OD Tablet:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Tofastar OD Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Tofastar OD Tablet can be consumed with or without food, though consistent timing is recommended.

How Tofastar OD Tablet works:

Tofastar OD Tablet is a medication that inhibits Janus kinase. Its mechanism of action involves suppressing Janus kinase enzyme activity, thereby reducing immune system response and inflammation characteristic of rheumatic conditions and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions from concomitant use of Tofastar OD Tablet and alcohol.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Tofastar OD Tablet during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Tofastar OD Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Operating a vehicle is typically unaffected by Tofastar OD Tablet.

KidneyKidneyCAUTION

Patients with advanced kidney impairment should exercise caution when using Tofastar OD Tablets. Dosage modification may be necessary; physician consultation is recommended.

LiverLiverCAUTION

Patients with significant hepatic impairment should exercise caution when using Tofastar OD Tablets, as dose modification may be necessary. Physician consultation is advised.

What if you forget to take Tofastar OD Tablet :

Should you forget a Tofastar OD Tablet dose, take it immediately. If your next dose is nearly due, however, omit the missed dose and resume your usual dosing schedule. Never take a double dose.

Facts to Know About Tofastar OD Tablet

LabelValue
Chemical Classification Pyrrolopyrimidine Analog
Developing Habits No.
Type of Treatment Pain Relievers
Actions JAK inhibitors

FAQs on Tofastar OD Tablet

Tell your doctor about any liver problems before taking Tofastar OD Tablet. This is important because Tofastar OD Tablet may sometimes raise liver enzyme levels, so your liver function should be checked beforehand. While Tofastar OD Tablet can be used in those with mild to moderate liver impairment, it shouldn't be prescribed to patients with severe liver impairment.
Tofastar OD Tablets may increase the risk of certain cancers, such as lymphoma and skin cancer, by impacting the immune system. Therefore, tell your doctor about any history of cancer.
Tofastar OD Tablets treat moderate to severe rheumatoid arthritis, a joint inflammatory disease. This medication is used when prior treatments proved ineffective or unsuitable. It may also be prescribed early if initial medications fail to provide adequate relief. Tofastar OD Tablets can be administered alone or in conjunction with other drugs, like methotrexate.
You may start feeling better within 2 to 8 weeks of taking Tofastar OD Tablet, but it typically takes 3 to 6 months to experience its full benefits.
Before and during Tofastar OD Tablet treatment, blood tests may be necessary to monitor for anemia, neutropenia, lymphopenia, high cholesterol, and elevated liver enzymes. These tests help ensure the medication isn't causing adverse effects. Your doctor might also recommend a tuberculosis test beforehand, as Tofastar OD Tablet could worsen an existing infection.
Tofastar OD Tablet modifies the immune system, potentially lowering resistance to infection and increasing the risk of serious infections, such as tuberculosis, and potentially life-threatening systemic fungal, bacterial, or viral infections. Hospital treatment is recommended for such infections.
Tocilizumab and Tofastar OD Tablet shouldn't be taken together. Tofastar OD Tablet's effect on the immune system means it shouldn't be combined with other immunosuppressants. Concurrent use significantly raises infection risk and may cause additional health problems.
Tofastar OD Tablet
387
MRP 448
13% off